BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,717 | -44.1% | 414,000 | -54.7% | 0.01% | -42.1% |
| Q2 2023 | $711,732 | -31.1% | 914,000 | -34.1% | 0.02% | -32.1% |
| Q1 2023 | $1,032,746 | +64.1% | 1,387,000 | 0.0% | 0.03% | +64.7% |
| Q4 2022 | $629,351 | -23.1% | 1,387,000 | 0.0% | 0.02% | -26.1% |
| Q3 2022 | $818,000 | +8.5% | 1,387,000 | 0.0% | 0.02% | +15.0% |
| Q2 2022 | $754,000 | -8.2% | 1,387,000 | 0.0% | 0.02% | +5.3% |
| Q1 2022 | $821,000 | -15.4% | 1,387,000 | +3.6% | 0.02% | -5.0% |
| Q4 2021 | $970,000 | -45.8% | 1,339,000 | +3.2% | 0.02% | -48.7% |
| Q3 2021 | $1,790,000 | -42.1% | 1,297,000 | -31.0% | 0.04% | -44.3% |
| Q2 2021 | $3,089,000 | -11.5% | 1,881,000 | -10.3% | 0.07% | -14.6% |
| Q1 2021 | $3,492,000 | – | 2,096,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |